Macquarie Group LTD Iovance Biotherapeutics, Inc. Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

A detailed history of Macquarie Group LTD transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 3,190,036 shares of IOVA stock, worth $26 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,190,036

Holding current value

$26 Million

% of portfolio

0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.28 - $11.9 $23.2 Million - $38 Million	3,190,036 New	3,190,036 $30 Million
Q1 2024 May 14, 2024	BUY	$7.59 - $17.47 $926,382 - $2.13 Million	122,053 New	122,053 $1.81 Million
Q1 2023 May 15, 2023	SELL	$5.53 - $8.22 $3,727 - $5,540	-674 Reduced 1.19%	55,835 $341,000
Q4 2022 Feb 21, 2023	SELL	$5.62 - $10.0 $41,290 - $73,470	-7,347 Reduced 11.51%	56,509 $361,000
Q3 2022 Nov 14, 2022	SELL	$9.53 - $13.11 $24,177 - $33,260	-2,537 Reduced 3.82%	63,856 $634,000
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $10,979 - $31,545	1,721 Added 2.66%	66,393 $733,000
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $86,895 - $134,062	7,019 Added 12.17%	64,672 $1.08 Million
Q4 2021 Feb 11, 2022	BUY	$16.55 - $27.63 $156,761 - $261,711	9,472 Added 19.66%	57,653 $1.1 Million
Q3 2021 Nov 12, 2021	SELL	$20.35 - $26.63 $34,595 - $45,271	-1,700 Reduced 3.41%	48,181 $1.19 Million
Q2 2021 Aug 13, 2021	BUY	$16.33 - $33.07 $103,581 - $209,763	6,343 Added 14.57%	49,881 $1.3 Million
Q1 2021 May 14, 2021	BUY	$28.67 - $52.59 $132,140 - $242,387	4,609 Added 11.84%	43,538 $1.38 Million
Q4 2020 Feb 16, 2021	SELL	$28.04 - $50.26 $337,769 - $605,431	-12,046 Reduced 23.63%	38,929 $1.81 Million
Q3 2020 Nov 13, 2020	SELL	$27.75 - $36.3 $32,994 - $43,160	-1,189 Reduced 2.28%	50,975 $1.68 Million
Q2 2020 Aug 11, 2020	BUY	$27.21 - $41.0 $185,272 - $279,169	6,809 Added 15.01%	52,164 $1.43 Million
Q1 2020 May 15, 2020	SELL	$19.54 - $38.85 $315,316 - $626,922	-16,137 Reduced 26.24%	45,355 $1.36 Million
Q4 2019 Feb 14, 2020	SELL	$17.95 - $29.41 $38,269 - $62,702	-2,132 Reduced 3.35%	61,492 $1.7 Million
Q3 2019 Nov 14, 2019	BUY	$17.99 - $26.0 $611 - $884	34 Added 0.05%	63,624 $1.16 Million
Q2 2019 Aug 14, 2019	SELL	$9.78 - $24.52 $133,203 - $333,962	-13,620 Reduced 17.64%	63,590 $1.56 Million
Q1 2019 May 15, 2019	BUY	$8.41 - $11.26 $649,336 - $869,384	77,210 New	77,210 $734,000

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

241M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Iovance Biotherapeutics, Inc. Transaction History